نتائج البحث

Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data

• Authors : Aakjær, Mia; De Bruin, Marie Louise; Andersen, Morten

Subjects: adverse drug reactions; pharmacoepidemiology; pharmacovigilance

• Source: Aakjær , M , De Bruin , M L & Andersen , M 2024 , ' Epidemiological surveillance of drug safety using cumulative sequential analysis in

تفاصيل العنوان

Eliciting drug safety signals from patient records:a language-agnostic approach

• Authors : Kaas-Hansen, B.; Placido, D.; Rodriguez, C.

• Source: Kaas-Hansen , B , Placido , D , Rodriguez , C , Thorsen-Meyer , H , Gentile , S , Nielsen , A , Brunak , S , Jurgens , G & Andersen , S 2022 , ' Eliciting drug

تفاصيل العنوان

Influence of drug safety advisories on drug utilisation:an international interrupted time series and meta-analysis

• Authors : Morrow, Richard L.; Mintzes, Barbara; Souverein, Patrick C.

Subjects: health policy; health services research; medication safety

• Source: Morrow , R L , Mintzes , B , Souverein , P C , De Bruin , M L , Roughead , E E , Lexchin , J , Kemp-Casey , A , Puil , L , Sketris , I , Mangin , D , Hallgreen , C E , Pearson , S-A , Lopert , R ,

تفاصيل العنوان

Are Drug Safety Advisories Compatible with Physicians’ Information Behavior?:Semi-Structured Interviews with General Practitioners about Direct to Healthcare Professional Communication

• Authors : Møllebæk, Mathias; Kaae, Susanne

• Source: Møllebæk , M & Kaae , S 2022 , ' Are Drug Safety Advisories Compatible with Physicians’ Information Behavior? Semi-Structured

تفاصيل العنوان

Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada:A Longitudinal Cohort Study

• Authors : Morrow, Richard L.; Mintzes, Barbara; Souverein, Patrick C.

• Source: Morrow , R L , Mintzes , B , Souverein , P C , Hallgreen , C E , Ahmed , B , Roughead , E E , De Bruin , M L , Kristiansen , S B , Lexchin , J , Kemp-Casey , A , Sketris , I , Mangin , D , Pearson , S

تفاصيل العنوان

Influence of drug safety advisories on drug utilization:An international interrupted time series and meta-analysis study

• Authors : Morrow, Richard L.; Mintzes, Barbara; Souverein, Patrick C.

• Source: Morrow , R L , Mintzes , B , Souverein , P C , De Bruin , M L , Roughead , E E , Lexchin , J , Kemp-Casey , A , Puil , L , Sketris , I , Mangin , D , Hallgreen , C E , Pearson , S-A , Lopert , R ,

تفاصيل العنوان

A common data model for harmonization in the nordic pregnancy drug safety studies (Norpress)

• Authors : Cohen, Jacqueline M.; Cesta, Carolyn E.; Kjerpeseth, Lars

• Source: Cohen , J M , Cesta , C E , Kjerpeseth , L , Leinonen , M K , Hálfdánarson , Ó , Karlstad , Ø , Karlsson , P , Andersen , M , Furu , K & Hjellvik , V 2021 , ' A common data model for harmonization

تفاصيل العنوان

Linkage between the Danish National Health Service Prescription Database, the Danish Fetal Medicine Database, and other Danish registries as a tool for the study of drug safety in pregnancy

• Authors : Pedersen, Lars H; Petersen, Olav B; Nørgaard, Mette

Subjects: Journal Article

• Source: Pedersen , L H , Petersen , O B , Nørgaard , M , Ekelund , C , Pedersen , L , Tabor , A & Sørensen , H T 2016 , ' Linkage between the Danish National Health Service Prescription Database, the Danish

تفاصيل العنوان

Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran

• Authors : Holt, Anders; Strange, Jarl E.; Rasmussen, Peter Vibe

Subjects: Atrial fibrillation; Azole agents; Drug safety

• Source: Holt , A , Strange , J E , Rasmussen , P V , Blanche , P , Nouhravesh , N , Jensen , M H , Schjerning , A M , Schou , M , Torp-Pedersen , C , Gislason , G H , Hansen , M L , McGettigan , P & Lamberts

تفاصيل العنوان

Impact of regulatory interventions to restrict the combined use of renin-angiotensin system-acting agents: A Danish nationwide drug utilisation study

• Authors : Sindahl, Per; Ofori-Asenso, Richard; Hallgreen, Christine Erikstrup

Subjects: ACE inhibitors; angiotensin II receptor blockers; drug safety

• Source: Sindahl , P , Ofori-Asenso , R , Hallgreen , C E , Kemp , K , Gardarsdottir , H & Bruin , M L D 2022 , ' Impact of regulatory interventions to restrict the combined use of renin-angiotensin

تفاصيل العنوان